Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Preclinical models of stem cell-mediated analgesia and tissue repair: mechanisms, challenges, and future directions

Zhu M., Zhang H., Liang L., Wu S., Chen J.

Narrative Review on Disc Degeneration, Spinal Cord Injury, Chronic Inflammation, published in Front Cell Neurosci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Cell Neurosci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41890213
PMCID
PMC13012907
DOI
10.3389/fncel.2026.1787909

Abstract (original English)

As an emerging biological therapeutic approach, stem cell therapy demonstrates broad application prospects in analgesia and tissue regeneration, particularly achieving significant advances in treating conditions such as spinal cord injury and intervertebral disc degeneration. In recent years, preclinical model studies have deepened our understanding of the mechanisms underlying stem cell-mediated pain relief and tissue repair, revealing their potential to regulate inflammatory responses, promote nerve regeneration, and repair damaged tissues through multiple pathways. However, the heterogeneity of preclinical models and the discrepancies between these models and clinical practice, coupled with often insufficient critical appraisal of study quality, remain critical issues requiring urgent resolution in this field. This narrative review systematically summarizes the fundamental theories and key mechanisms underlying stem cell-mediated analgesia and regeneration. It comprehensively evaluates the advantages and limitations of different animal models, critically analyzes major controversies and technical challenges in research, and identifies key directions for future studies. The literature discussed herein was identified through searches in PubMed and Web of Science databases, focusing on recent preclinical studies (primarily within the last decade) involving stem cells, pain mode

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research